| Julia M Pierce, CRNA | |
|
99 Route 37 W, Toms River, NJ 08755-6423 | |
| (732) 557-8000 | |
| Not Available |
| Full Name | Julia M Pierce |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 7 Years |
| Location | 99 Route 37 W, Toms River, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972027241 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 26NJ00746200 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Deborah Heart And Lung Center | Browns mills, NJ | Hospital |
| Ocean Medical Center | Brick, NJ | Hospital |
| Inspira Medical Center Vineland | Vineland, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New Jersey Healthcare Specialists Pc | 2668385253 | 554 |
| North American Partners In Anesthesia Of New Jersey Llc | 5890867410 | 226 |
| Professional Service Fund Of Deborah- Anesthesia | 9133163504 | 25 |
News Archive
Genmab A/S has announced it has initiated a Phase II study of HuMax-EGFr (zalutumumab) in combination with chemo-radiation to treat non small cell lung cancer (NSCLC).
Cancer Research UK scientists have shown that it may soon be possible to offer women a genetic test to assess their risk of breast cancer which could aid early diagnosis for those at high risk of the disease. Their findings are revealed in the New England Journal of Medicine today (Wednesday).
Mammography Reporting System, Inc. (MRS) will demonstrate their newest high risk indicator at RSNA 2009, in Chicago. MRS is the only company in the industry offering three separate high risk indicators to alert radiologists of potentially at-risk patients at the very point they interpret a mammogram.
Low oxygen levels in the heart have long been known to produce life-threatening arrhythmias, even sudden death. Until now, it was not clear how.
A new treatment may help patients with a chronic kidney condition that can also lead to heart problems and premature death, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
› Verified 4 days ago
| Entity Name | New Jersey Healthcare Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174585780 PECOS PAC ID: 2668385253 Enrollment ID: O20031110000555 |
News Archive
Genmab A/S has announced it has initiated a Phase II study of HuMax-EGFr (zalutumumab) in combination with chemo-radiation to treat non small cell lung cancer (NSCLC).
Cancer Research UK scientists have shown that it may soon be possible to offer women a genetic test to assess their risk of breast cancer which could aid early diagnosis for those at high risk of the disease. Their findings are revealed in the New England Journal of Medicine today (Wednesday).
Mammography Reporting System, Inc. (MRS) will demonstrate their newest high risk indicator at RSNA 2009, in Chicago. MRS is the only company in the industry offering three separate high risk indicators to alert radiologists of potentially at-risk patients at the very point they interpret a mammogram.
Low oxygen levels in the heart have long been known to produce life-threatening arrhythmias, even sudden death. Until now, it was not clear how.
A new treatment may help patients with a chronic kidney condition that can also lead to heart problems and premature death, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
› Verified 4 days ago
| Entity Name | Professional Service Fund Of Deborah- Anesthesia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902852015 PECOS PAC ID: 9133163504 Enrollment ID: O20050616000283 |
News Archive
Genmab A/S has announced it has initiated a Phase II study of HuMax-EGFr (zalutumumab) in combination with chemo-radiation to treat non small cell lung cancer (NSCLC).
Cancer Research UK scientists have shown that it may soon be possible to offer women a genetic test to assess their risk of breast cancer which could aid early diagnosis for those at high risk of the disease. Their findings are revealed in the New England Journal of Medicine today (Wednesday).
Mammography Reporting System, Inc. (MRS) will demonstrate their newest high risk indicator at RSNA 2009, in Chicago. MRS is the only company in the industry offering three separate high risk indicators to alert radiologists of potentially at-risk patients at the very point they interpret a mammogram.
Low oxygen levels in the heart have long been known to produce life-threatening arrhythmias, even sudden death. Until now, it was not clear how.
A new treatment may help patients with a chronic kidney condition that can also lead to heart problems and premature death, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
› Verified 4 days ago
| Entity Name | North American Partners In Anesthesia Of New Jersey Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548433048 PECOS PAC ID: 5890867410 Enrollment ID: O20080626000318 |
News Archive
Genmab A/S has announced it has initiated a Phase II study of HuMax-EGFr (zalutumumab) in combination with chemo-radiation to treat non small cell lung cancer (NSCLC).
Cancer Research UK scientists have shown that it may soon be possible to offer women a genetic test to assess their risk of breast cancer which could aid early diagnosis for those at high risk of the disease. Their findings are revealed in the New England Journal of Medicine today (Wednesday).
Mammography Reporting System, Inc. (MRS) will demonstrate their newest high risk indicator at RSNA 2009, in Chicago. MRS is the only company in the industry offering three separate high risk indicators to alert radiologists of potentially at-risk patients at the very point they interpret a mammogram.
Low oxygen levels in the heart have long been known to produce life-threatening arrhythmias, even sudden death. Until now, it was not clear how.
A new treatment may help patients with a chronic kidney condition that can also lead to heart problems and premature death, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Julia M Pierce, CRNA 3 Lexington Ct, Medford, NJ 08055-8545 Ph: (160) 974-42797 | Julia M Pierce, CRNA 99 Route 37 W, Toms River, NJ 08755-6423 Ph: (732) 557-8000 |
News Archive
Genmab A/S has announced it has initiated a Phase II study of HuMax-EGFr (zalutumumab) in combination with chemo-radiation to treat non small cell lung cancer (NSCLC).
Cancer Research UK scientists have shown that it may soon be possible to offer women a genetic test to assess their risk of breast cancer which could aid early diagnosis for those at high risk of the disease. Their findings are revealed in the New England Journal of Medicine today (Wednesday).
Mammography Reporting System, Inc. (MRS) will demonstrate their newest high risk indicator at RSNA 2009, in Chicago. MRS is the only company in the industry offering three separate high risk indicators to alert radiologists of potentially at-risk patients at the very point they interpret a mammogram.
Low oxygen levels in the heart have long been known to produce life-threatening arrhythmias, even sudden death. Until now, it was not clear how.
A new treatment may help patients with a chronic kidney condition that can also lead to heart problems and premature death, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
› Verified 4 days ago
Mr. Christopher Washington, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 99 Rte 37 W, Toms River, NJ 08755 Phone: 609-652-1000 | |
Nicholas Jesus Flores, DNP, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 99 Rte 37 W, Toms River, NJ 08755 Phone: 732-557-8000 | |
Haillye Hughes, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 99 Route 37 W, Toms River, NJ 08755 Phone: 732-557-8000 | |
Lizeth Vanessa Nunez, MSN, CRNA, APN-A Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 99 Route 37 W, Toms River, NJ 08755 Phone: 732-557-8000 | |
Bethany Lynn Lizardi, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 99 Highway 37 W, Toms River, NJ 08755 Phone: 732-779-8100 | |
Monica Daigbe, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 99 Highway 37 W, Toms River, NJ 08755 Phone: 732-557-8000 | |
Allison Kay Close, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 99 Highway 37 W, Toms River, NJ 08755 Phone: 732-557-8000 |